FindTrial
Sign In

To study the effectiveness of Guduchi Churna in Vatarakta

A clinical study to evaluate the efficacy of guduchi churna in the management of Vatarakta with special reference to Hyperurecaemia - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/073118
Enrollment
30
Registered
2024-08-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E790- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease Health Condition 2: E790- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease Health Condition 3: E790- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease

Interventions

None listed

Sponsors

Principal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having serum uric acid level more than 7 mg/dl (male) and more than 6 mg/dl (females) with or without any associated symptoms of joint inflammation

Exclusion criteria

Exclusion criteria: patients suffering from any other form of arthrirtis like osteoarthritis, tubercular arthritis, rheumatoid arthritis, chronic renal disease , respiratory illness cardiac and hepatic disorders, active malignancy.

Design outcomes

Primary

MeasureTime frame
To have a decrease in level of serum uric acidTimepoint: 4 WEEKS—

Secondary

MeasureTime frame
To assess the clinical safety of guduchi churna in management of Vatarakta wsr to hyperurecemiaTimepoint: 30 days—

Countries

India

Contacts

Public ContactKavita

Rajiv Gandhi Govt Post Graduate Ayurvedic College and Hospital

dr.skumarthakur@gmail.com9816195001

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026